Document is current
Any future updates will be listed below
-
Authors
Madkhali, Aymen M.
Abdulhaq, Ahmed A.
Atroosh, Wahib M.
Ghzwani, Ahmad Hassn
Zain, Khalid Ammash
Ghailan, Khalid Y.
Hamali, Hassan A.
Mobarki, Abdullah A.
Eisa, Zaki M.
Lau, Yee-Ling
Al-Mekhlafi, Hesham M.
-
Funding
Funding for this research was provided by:
Jazan University (RG-2-1)
- License Information
-
More Information
Article History
Received: 16 August 2021
Accepted: 15 September 2021
First Online: 25 September 2021
Declarations
:
: Ethical approval for the current study was obtained from the Ethics Committee of Jazan University (Ref. no. REC39/6–261). The study was also approved by the Ethics Committee of the Health Affairs Directorate of King Fahd Central Hospital, Jazan (Registry no. 086). Before data collection, the patients, and their guardians in case of children, were informed about the objectives of the study and their role. They were also informed that their participation was entirely voluntary and that they could withdraw at any time without giving any reasons whatsoever and without any consequences in respect of their health care. Then, written signed consent was obtained from the adult participants or from the children’s parents or guardians. The patients were treated for malaria at the respective healthcare facilities according to the national malaria drug policy.
: All authors have agreed and consented to publish the manuscript.
: The authors declare no competing interests.
